 | Up a level |
Fasshauer, Maria; Borte, Michael; Bitzenhofer, Michaela; Pausch, Christine; Pittrow, David; Park, Michelle; Gladiator, André; Jandus, Peter (2023). Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases. Advances in therapy, 40(12), pp. 5168-5187. Springer 10.1007/s12325-023-02649-0
Fasshauer, Maria; Borte, Michael; Bitzenhofer, Michaela; Pausch, Christine; Pittrow, David; Park, Michelle; Gladiator, André; Jandus, Peter (2022). Real-world utilization, safety and patient experience of 20% subcutaneous immunoglobuin in patients with primary immunodeficiencies: final data from the core study (Unpublished). In: ESID Kongress Gothenburg 2022.
